Medical treatment of gallstones.
D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced; D001646:Bile / Q000032:analysis; D002635:Chenodeoxycholic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy*; D002779:Cholestasis / Q000139:chemically induced; D002784:Cholesterol; D003967:Diarrhea / Q000139:chemically induced; D006801:Humans; D050356:Lipid Metabolism; D008095:Lithocholic Acid / Q000009:adverse effects; D008099:Liver / Q000378:metabolism; D008253:Macaca mulatta; D010634:Phenobarbital / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010919:Placebos
D010713:Phosphatidylcholines; D010919:Placebos; D002635:Chenodeoxycholic Acid; D008095:Lithocholic Acid; D002784:Cholesterol; D010634:Phenobarbital